JAK3 and rheumatoid arthritis: JAK3 appeared to play crucial roles in immune and nonimmune physiology since tofacitinib, a selective JAK3 inhibitor is a treatment for certain inflammatory diseases and has an immunosuppressive activity in RA (Kumar et al. 2021).